Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $218.26 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $54.39 | 3 | $0 (2024) |
| Horizon Therapeutics plc | $44.29 | 2 | $0 (2023) |
| Bioventus LLC | $32.68 | 2 | $0 (2024) |
| Heron Therapeutics, Inc. | $23.97 | 1 | $0 (2024) |
| Pylant Medical | $22.23 | 1 | $0 (2023) |
| Organogenesis Inc. | $20.61 | 1 | $0 (2023) |
| Pacira Pharmaceuticals Incorporated | $20.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56.63 | 3 | Heron Therapeutics, Inc. ($23.97) |
| 2023 | $146.38 | 7 | Horizon Therapeutics plc ($44.29) |
| 2022 | $15.25 | 1 | Bioventus LLC ($15.25) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Bone Health | ||||||
| 09/23/2024 | Heron Therapeutics, Inc. | ZYNRELEF (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: POST SURGICAL PAIN RELIEF | ||||||
| 06/10/2024 | Bioventus LLC | EXOGEN ULTRASOUND BONE HEALING SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: DEVICES | ||||||
| 11/02/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Pain Management | ||||||
| 09/25/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Bone Health | ||||||
| 06/14/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Wound Care | ||||||
| 03/28/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: KRYSTEXXA | ||||||
| 02/22/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Bone Health | ||||||
| 01/25/2023 | Pylant Medical | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 01/20/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: KRYSTEXXA | ||||||
| 05/17/2022 | Bioventus LLC | Exogen Ultrasound Bone Healing System (Device) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,044 | 4,401 | $332,757 | $119,584 |
| 2022 | 18 | 2,170 | 6,285 | $369,487 | $137,282 |
| 2021 | 18 | 2,092 | 5,457 | $326,484 | $141,321 |
| 2020 | 15 | 1,785 | 5,639 | $248,466 | $92,737 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 374 | 519 | $94,977 | $40,436 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 307 | 509 | $65,661 | $27,682 | 42.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 208 | 303 | $38,413 | $12,686 | 33.0% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2023 | 14 | 23 | $40,227 | $9,347 | 23.2% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 188 | 298 | $28,222 | $7,067 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $11,233 | $4,071 | 36.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 190 | 503 | $5,030 | $3,763 | 74.8% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 71 | 97 | $8,051 | $2,635 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 185 | 310 | $13,950 | $2,630 | 18.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 89 | 123 | $5,016 | $2,543 | 50.7% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2023 | 37 | 73 | $3,570 | $1,810 | 50.7% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 44 | 57 | $6,106 | $1,663 | 27.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 220 | 1,438 | $7,190 | $1,149 | 16.0% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2023 | 21 | 32 | $1,305 | $708.78 | 54.3% |
| 73080 | X-ray of elbow, minimum of 3 views | Office | 2023 | 24 | 35 | $1,664 | $668.11 | 40.2% |
| 73140 | X-ray of finger, minimum of 2 views | Office | 2023 | 14 | 18 | $792.00 | $380.97 | 48.1% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 11 | 16 | $1,350 | $343.51 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 370 | 505 | $86,997 | $39,343 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 366 | 574 | $70,662 | $30,389 | 43.0% |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | Office | 2022 | 25 | 34 | $59,466 | $22,221 | 37.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 238 | 389 | $47,389 | $15,706 | 33.1% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 202 | 315 | $30,591 | $7,374 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $9,747 | $4,063 | 41.7% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 106 | 166 | $6,952 | $3,306 | 47.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 353 | 3,498 | $17,490 | $2,934 | 16.8% |
About Paul Powers, P.A.-C
Paul Powers, P.A.-C is a Medical healthcare provider based in Duncan, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699837203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Powers, P.A.-C has received a total of $218.26 in payments from pharmaceutical and medical device companies, with $56.63 received in 2024. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($218.26).
As a Medicare-enrolled provider, Powers has provided services to 8,091 Medicare beneficiaries, totaling 21,782 services with total Medicare billing of $490,923. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Duncan, OK
- Active Since 12/14/2006
- Last Updated 05/15/2019
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1699837203
Products in Payments
- EVENITY (Biological) $54.39
- KRYSTEXXA (Biological) $44.29
- ZYNRELEF (Drug) $23.97
- Puraply (Medical Supply) $20.61
- Exparel (Drug) $20.09
- EXOGEN ULTRASOUND BONE HEALING SYSTEM (Device) $17.43
- Exogen Ultrasound Bone Healing System (Device) $15.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.